Medicine and Dentistry
Androgen Receptor
100%
Prostate Cancer
100%
Cell Line
100%
Androgen
55%
Androgen Deprivation Therapy
44%
Mesenchymal-Epithelial Transition
22%
Fetal Calf Serum
22%
Dextran
22%
Flutamide
22%
Cell Growth
11%
Carcinogenesis
11%
Cell Proliferation
11%
Castration Resistant Prostate Cancer
11%
Cancer Growth
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
MTT Assay
11%
Apalutamide
11%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
11%
Prostate Cancer Cell Line
11%
Steroidogenesis
11%
Enzalutamide
11%
Glucocorticoid Receptor
11%
Neuroscience
Androgen
100%
Cell Line
100%
Androgen Receptor
100%
Prostate
33%
Epithelial Mesenchymal Transition
22%
Dextran
22%
Flutamide
22%
Fetal Bovine Serum
22%
Bicalutamide
22%
Glucocorticoid Receptor
11%
Enzalutamide
11%
Cell Proliferation
11%
Cell Growth
11%
Carcinogenesis
11%
MTT Assay
11%
Immunology and Microbiology
Cell Line
100%
Epithelial Mesenchymal Transition
50%
Fetal Calf Serum
50%
Prostate
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Cell Proliferation
25%
Glucocorticoid
25%
Wild Type
25%
Potential Difference
25%
Cell Growth
25%
Prostate Cancer Cell Line
25%
Steroidogenesis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
100%
Prostate Cancer
100%
Androgen
100%
Bicalutamide
22%
Flutamide
22%
Dextran
22%
Enzalutamide
11%
Cancer Growth
11%
Castration Resistant Prostate Cancer
11%
Carcinogenesis
11%
Glucocorticoid Receptor
11%
Apalutamide
11%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
11%
Veterinary Science and Veterinary Medicine
Prostate Cancer
100%
Androgen
100%
Androgen Receptor
100%
Epithelial-Mesenchymal Transition
22%
Bicalutamide
22%
Flutamide
22%
Cancer Cell
11%
Steroidogenesis
11%
Enzalutamide
11%
Glucocorticoid Receptor
11%